Demographic and Clinical Parameters

Survival

P-value

Yes (n = 24)

No (n = 3)

Gender

Male

16 (66.7%)

1 (33.3%)

0.393

Female

8 (33.3%)

2 (66.7%)

Clinical Stage

Stage I

1 (4.2%)

0.0

0.874

Stage II

6 (25%)

1 (33.3%)

Stage III

10 (41.7%)

1 (33.3%)

Stage IV

7 (29.2%)

1 (33.3%)

Bulky Disease

Yes

10 (41.7%)

2 (66.7%)

0.482

No

14 (58.3%)

1 (33.3%)

BM (Bone Marrow)

Positive

5 (20.8%)

1 (33.3%)

0.189

Negative

19 (79.2%)

2 (66.7%)

CNS

Positive

5 (20.8%)

1 (33.3%)

*<0.001

Negative

19 (79.2%)

2 (66.7%)

LDH

Normal

8 (33.3%)

0.0

0.393

Institutional ULN

16 (66.7%)

3 (100%)

HB

Low

17 (70.8%)

2 (66.7%)

0.804

Normal

7 (29.2%)

1 (33.3%)